Adrenergic nervous activity in patients after surgical correction of tetralogy of Fallot.
暂无分享,去创建一个
[1] V. Somers,et al. Heart Rate Variability: , 2003, Journal of cardiovascular electrophysiology.
[2] J. Sponring,et al. Regional Wall Motion and Abnormalities of Electrical Depolarization and Repolarization in Patients After Surgical Repair of Tetralogy of Fallot , 2001, Circulation.
[3] S. Siu,et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study , 2000, The Lancet.
[4] D. Chemla,et al. Arrhythmic right ventricular cardiomyopathy 1 113 June 2000 , 2000 .
[5] R. Peverill. Possible mechanisms of increased blood viscosity in systemic hypertension. , 2000, The American journal of cardiology.
[6] G. Danieli,et al. Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy map to chromosome 1q42-43. , 2000, The American journal of cardiology.
[7] L. Daliento,et al. Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot , 1999, Heart.
[8] Geoffrey I. Webb,et al. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. , 1997, Journal of the American College of Cardiology.
[9] A. Malliani,et al. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .
[10] G. Breithardt,et al. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .
[11] M. Dae,et al. Scintigraphy of myocardial innervation with metaiodobenzylguanidine (MIBG): Is there a clinical application? , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[12] G. Breithardt,et al. Regional Myocardial Sympathetic Dysinnervation in Arrhythmogenic Right Ventricular Cardiomyopathy: An Analysis Using 123I‐Meta‐Iodobenzylguanidine Scintigraphy , 1994, Circulation.
[13] D. Zipes,et al. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. , 1993, Journal of the American College of Cardiology.
[14] M. Schlepper,et al. 123I-metaiodobenzylguanidine scintigraphy in the detection of irregular regional sympathetic innervation in long QT syndrome. , 1993, European heart journal.
[15] A. Camm,et al. Asymmetry of cardiac [1231] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a "clinically normal" heart , 2022 .
[16] Robert H. Anderson,et al. The morphologic substrates for pediatric arrhythmias , 1991, Cardiology in the Young.
[17] K. Nakajima,et al. Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. , 1990, American heart journal.
[18] M. Akers,et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. , 1988, Circulation.
[19] D. Zipes,et al. Interruption of sympathetic and vagal-mediated afferent responses by transmural myocardial infarction. , 1985, Circulation.
[20] L. Freeman,et al. Nuclear medicine annual. , 1982 .